Nuvation Bio Inc. financial data

Symbol
NUVB, NUVB-WT on NYSE
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 834% % -33%
Quick Ratio 6.6% %
Debt-to-equity 64% % 412%
Return On Equity -57% % 54%
Return On Assets -35% % 64%
Operating Margin -339% % 96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 342,833,433 shares 1.9%
Common Stock, Shares, Outstanding 337,837,872 shares 0%
Entity Public Float $496,965,132 USD -100%
Common Stock, Value, Issued $1,421,273,000 USD 3.4%
Weighted Average Number of Shares Outstanding, Basic 341,541 shares 27%
Weighted Average Number of Shares Outstanding, Diluted 341,541 shares 27%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $13,120,000 USD 1705%
Revenue from Contract with Customer, Excluding Assessed Tax $62,902,000 USD 699%
Research and Development Expense $115,106,000 USD 16%
General and Administrative Expense $28,156,000 USD -13%
Operating Income (Loss) $213,064,000 USD 64%
Nonoperating Income (Expense) $8,437,000 USD -66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $204,627,000 USD 64%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $204,627,000 USD 64%
Earnings Per Share, Basic -0.6 USD/shares 72%
Earnings Per Share, Diluted -0.6 USD/shares 72%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $164,086,000 USD 359%
Marketable Securities, Current $365,125,000 USD -22%
Inventory, Net $11,411,000 USD
Assets, Current $571,519,000 USD 8.6%
Property, Plant and Equipment, Net $564,000 USD -3.8%
Operating Lease, Right-of-Use Asset $3,918,000 USD 63%
Other Assets, Noncurrent $7,607,000 USD 13%
Assets $594,822,000 USD 10%
Accounts Payable, Current $9,479,000 USD 49%
Accrued Liabilities, Current $45,183,000 USD 38%
Contract with Customer, Liability, Current $7,515,000 USD -32%
Liabilities, Current $82,231,000 USD 41%
Contract with Customer, Liability, Noncurrent $13,614,000 USD
Accrued Income Taxes, Noncurrent $286,000 USD -58%
Operating Lease, Liability, Noncurrent $2,543,000 USD 162%
Liabilities $289,106,000 USD 276%
Common Stocks, Including Additional Paid in Capital $116,986,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $187,000 USD -133%
Retained Earnings (Accumulated Deficit) $1,115,370,000 USD -22%
Stockholders' Equity Attributable to Parent $305,716,000 USD -34%
Liabilities and Equity $594,822,000 USD 10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $42,627,000 USD -171%
Net Cash Provided by (Used in) Financing Activities $548,000 USD 2510%
Net Cash Provided by (Used in) Investing Activities $54,182,000 USD 618%
Common Stock, Shares Authorized 1,060,000,000 shares 206%
Common Stock, Shares, Issued 337,837,872 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,254,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $164,086,000 USD 359%
Deferred Tax Assets, Valuation Allowance $244,154,000 USD 2.5%
Deferred Tax Assets, Gross $244,965,000 USD 0.98%
Operating Lease, Liability $4,423,000 USD 68%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $205,387,000 USD 64%
Lessee, Operating Lease, Liability, to be Paid $4,980,000 USD 79%
Property, Plant and Equipment, Gross $1,748,000 USD 20%
Operating Lease, Liability, Current $1,880,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,407,000 USD 68%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,192,000 USD 24%
Operating Lease, Weighted Average Discount Rate, Percent 0.0902 pure 29%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $557,000 USD 290%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,219,000 USD 613%
Deferred Tax Assets, Operating Loss Carryforwards $127,345,000 USD 18%
Unrecognized Tax Benefits $10,133,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year Four $162,000 USD
Share-based Payment Arrangement, Expense $35,894,000 USD 11%
Interest Expense $5,121,000 USD